Precision. Performance. Results.
Excellent precision, flexibility, and proven clinical results1 in the iliacs.
Precision
- Tri-axial technology to ensure precise stent placement
Performance
- Flexible nitinol material
- 12 radiopaque nitinol markers (6 on each end) for visibility
Clinical Results
- 98.9% clinically driven freedom from TLR at 9 months
- 92.1% primary patency at 2 years in iliacs1
- 84.8% primary patency in TASC D lesions at 2 years in iliacs*1
High Freedom from Clinically Driven TLR through 3 years
Significant Sustained Improvement in Walking Capacity
Tri-Axial Technology Specifications
Stent Size Matrix
| Lengths (mm) | |||||||
|---|---|---|---|---|---|---|---|
| 20 | 30 | 40 | 60 | 80 | 100 | ||
| Stent Diameter (mm) | 6.0 | 6F/8F | 6F/8F | 6F/8F | 6F/8F | 6F/8F | 6F/8F |
| 7.0 | 6F/8F | 6F/8F | 6F/8F | 6F/8F | 6F/8F | 6F/8F | |
| 8.0 | 6F/8F | 6F/8F | 6F/8F | 6F/8F | 6F/8F | 6F/8F | |
| 9.0 | 6F/8F | 6F/8F | 6F/8F | 6F/8F | 6F/8F | 6F/8F | |
| 10.0 | 6F/8F | 6F/8F | 6F/8F | 6F/8F | 6F/8F | 6F/8F | |
| Sheath/Guide Compatibility | |||||||
Compatible with 0.035" guide wire only - use of an undersized guide wire with insufficient support may cause kinking in the stent delivery system.**
Data on file at Abbott.
*Combined clinical results from BRAVISSIMO study where 54%/46% of TASC D lesions were treated with Absolute Pro™ Vascular Self-Expanding Stent System / Omnilink Elite™ Vascular Balloon-Expandable Stent System respectively.
**Absolute Pro™ .035 Self-Expanding Stent System Instructions For Use (IFU). Refer to IFU for additional information.
References
- Donato, G. et al. 24-Month Data from the BRAVISSIMO: A Large-Scale Prospective Registry on Iliac Stenting for TASC A & B and TASC C & D Lesions. Annals of Vascular Surgery. 2015; 29(4): 738-750.
MAT-2116361 v2.0